Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pembrolizumab + Platinum Doublets Without Radiation for Patients With PD-L1 ≥50% Locally Advanced Non-small Cell Lung Cancer: a Multicenter Prospective Single Arm Phase II Study

NCT04153734 is registered in ClinicalTrials.gov with Kobe Minimally Invasive Cancer Center as lead sponsor.

NCT NCT04153734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pembrolizumab + Platinum Doublets Without Radiation for Patients With PD-L1 ≥50% Locally Advanced Non-small Cell Lung Cancer: a Multicenter Prospective Single Arm Phase II Study
Lead sponsor
Kobe Minimally Invasive Cancer Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 1, 2019
Completion date
November 30, 2023
Enrollment
21 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced non-small cell lung cancer